Company intelligence / Profile preview
Vanqua Bio
Chicago, Illinois, United Statesvanquabio.com ↗
- Ownership
- Public · N/A
- Employees
- ~75
- Development stage
- Preclinical
01
Overview
Vanqua Bio has advanced its lead candidate VQ‑101, a brain‑penetrant small molecule allosteric activator of glucocerebrosidase, into clinical development for Parkinson’s disease. The company leverages a proprietary patient-derived iPSC platform to identify novel therapies targeting lysosomal dysfunction and innate immune overactivation. Early results indicate promise in modulating key neurodegenerative pathways; the lead asset entered Phase Ib trials in late 2024.[3][6]
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Small molecules (notably allosteric activators of GCase)[3][9]Potentially others in early discovery for immune modulation[9]
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed; strong investor syndicate including Eli Lilly & Company [3].
Beyond the preview
Go deeper on Vanqua Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vanqua Bio.